Nuclea enters development partnerships for cancer tests

01/15/2014 | GenomeWeb Daily News (free registration)

Nuclea has entered into a deal with Nuvera Biosciences to jointly create a gene-based test to predict a breast cancer patient's response to endocrine therapy and taxane chemotherapy. The company also struck a deal with AccuGenomics to co-develop and test the use of a BCR-ABL assay in measuring the effectiveness of treatment for chronic myeloid leukemia.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR